[現代免疫療法と緊急事態:CAR T細胞療法とBTEの毒性,その管理,集中治療におけるその関連性]
Judit Grans-Siebel1, Jorge Garcia Borrega1, Boris Böll2
1Klinik I für Innere Medizin - Hämatologie/Onkologie, Internistische Intensivmedizin, Centrum für Integrierte Onkologie Aachen Bonn Köln Düsseldorf (CIO), Universitätsklinikum Köln, Kerpener Straße 62, 50937, Köln, Deutschland.
CAR T細胞療法のような新種の免疫療法は,血液がん患者にとって新しい希望をもたらしますが,サイトカイン放出症候群 (CRS) や神経毒性 (ICANS) などの重篤な副作用を引き起こし,集中治療管理を必要とします.
科学分野:
- 腫瘍学
- 免疫学
- クリティカル ケア 医療
さらに関連する動画
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
関連する概念動画
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Myocarditis III: Medical Management
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
